FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+2.8%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$720M
AUM Growth
+$720M
(-6.4%)
Cap. Flow
-$31.7M
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
45.97%
Holding
78
New
15
Increased
29
Reduced
14
Closed
5
Top Buys
| 1 |
ELGX
Endologix Inc
ELGX
|
$17.8M |
| 2 |
SI-BONE Inc
SIBN
|
$13.2M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$12.4M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$11.4M |
| 5 |
Codexis
CDXS
|
$8.88M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$46.8M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$18.3M |
| 3 |
Omnicell
OMCL
|
$16.4M |
| 4 |
Harvard Bioscience
HBIO
|
$13M |
| 5 |
Dynavax Technologies
DVAX
|
$12.5M |
Sector Composition
| 1 | Healthcare | 77.13% |
| 2 | Communication Services | 5.9% |
| 3 | Financials | 0.98% |
| 4 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares US Medical Devices ETF
IHI
$4.27B
| $1.83M | 0.25% |
7,580
| – | – |
|
52
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $1.69M | 0.23% |
18,241
| – | – |
|
53
LeMaitre Vascular
LMAT
$2.14B
| $1.39M | 0.19% |
49,532
+233
| +0.5% | +$6.52K |
|
|
CLLS
54
Cellectis
CLLS
$260M
| $1.18M | 0.16% |
75,843
+429
| +0.6% | +$6.69K |
|
|
55
Harvard Bioscience
HBIO
$21.1M
| $1.18M | 0.16% |
588,148
-6,482,090
| -92% | -$13M |
|
56
Transmedics
TMDX
$3.65B
| $783K | 0.11% |
+27,000
| New | +$783K |
|
57
Sarepta Therapeutics
SRPT
$1.98B
| $456K | 0.06% |
+3,000
| New | +$456K |
|
58
Pfizer
PFE
$141B
| $367K | 0.05% |
8,469
| – | – |
|
|
AGN
59
DELISTED
Allergan plc
AGN
| $361K | 0.05% |
+2,157
| New | +$361K |
|
60
Merck
MRK
$210B
| $356K | 0.05% |
4,247
| – | – |
|
61
Novartis
NVS
$248B
| $323K | 0.04% |
3,535
| – | -$37.5K |
|
62
Johnson & Johnson
JNJ
$429B
| $301K | 0.04% |
2,161
| – | – |
|
63
AbbVie
ABBV
$374B
| $299K | 0.04% |
4,114
| – | – |
|
64
Sanofi
SNY
$122B
| $288K | 0.04% |
6,650
| – | – |
|
65
Baxter International
BAX
$12.1B
| $267K | 0.04% |
+3,258
| New | +$267K |
|
66
Steris
STE
$23.9B
| $246K | 0.03% |
1,649
| – | – |
|
67
Thermo Fisher Scientific
TMO
$183B
| $234K | 0.03% |
797
| – | – |
|
68
Elevance Health
ELV
$72.4B
| $224K | 0.03% |
795
| – | – |
|
|
HRC
69
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $222K | 0.03% |
2,121
| – | – |
|
70
Grifois
GRFS
$6.53B
| $215K | 0.03% |
+10,166
| New | +$215K |
|
71
Amgen
AMGN
$153B
| $201K | 0.03% |
1,092
| – | – |
|
72
Danaher
DHR
$143B
| $200K | 0.03% |
+1,400
| New | +$200K |
|
|
DYNT
73
DELISTED
Dynatronics Corp
DYNT
| $194K | 0.03% |
117,619
+2,754
| +2% | +$4.54K |
|
74
Teleflex
TFX
$5.57B
| – | – |
-777
| Closed | -$235K |
|
75
Revvity
RVTY
$9.68B
| – | – |
-2,245
| Closed | -$216K |
|